Atak Zeliha, Rahimli Ocakoglu Sakine, Topal Serra, Macunluoglu Aslı Ceren
Department of Obstetrics and Gynecology, Bursa City Hospital, Bursa, Turkey.
Department of Anesthesiology and Intensive Care, Bursa City Hospital, Bursa, Turkey.
J Obstet Gynaecol. 2022 Oct;42(7):2709-2714. doi: 10.1080/01443615.2022.2099255. Epub 2022 Jul 19.
The aim of this study was to demonstrate the poor prognosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in unvaccinated pregnant women. In this retrospective study, the clinical and laboratory parameters of 26 pregnant or immediately postpartum patients, who were hospitalised and needed intensive care unit (ICU) follow-up due to coronavirus disease 2019 (COVID-19) infection were reported. All pregnant patients who followed up in the ICU were unvaccinated. The mortality rate was calculated as 34.62% in the patients included in the study who were admitted to the ICU. Among patients hospitalised in the ICU, the maternal mortality and stillbirth rates associated with COVID-19 infection were found to be 156.28/100,000 and 11.54%, respectively. Preterm birth occurred in 58.33% of the patients who delivered. 79.17% of the patients were delivered by caesarean section. Lymphopenia, high ferritin, interleukin-6, lactate dehydrogenase, D-dimer and C-reactive protein values were found to be associated with mortality. The course of pregnant patients with COVID-19 infection is not always predictable. Clinical and laboratory data should be evaluated in combination for disease prognosis. Adequate information should be given about the importance of vaccination.Impact Statement The SARS-CoV-2 infection has caused a public health crisis worldwide. As a result of studies on coronavirus disease 2019 (COVID-19) infected pregnant women, it was observed that there was an increase in maternal and perinatal mortality. There has been an increase in intensive care unit (ICU) admissions, especially after patients infected with the Delta variant. The pandemic continues with an unpredictable course of the new variants. Compared to the pre-pandemic period, COVID-19 infection caused a more than 10-fold increase in maternal mortality, particularly after the Delta variant. In intensive care follow-up, low lymphocyte count, high lactate dehydrogenase, D-dimer, C-reactive protein, ferritin and interleukin-6 values are indicators of poor prognosis. COVID-19 infection causes increased maternal mortality. Considering that all of the patients admitted to the ICU in our study were unvaccinated, pregnant women should be encouraged to get vaccinated.
本研究的目的是证明未接种疫苗的孕妇感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的预后较差。在这项回顾性研究中,报告了26例因2019冠状病毒病(COVID-19)感染而住院且需要重症监护病房(ICU)随访的孕妇或产后即刻患者的临床和实验室参数。所有在ICU接受随访的孕妇均未接种疫苗。纳入本研究的入住ICU的患者死亡率计算为34.62%。在入住ICU的患者中,与COVID-19感染相关的孕产妇死亡率和死产率分别为156.28/10万和11.54%。分娩的患者中有58.33%发生早产。79.17%的患者通过剖宫产分娩。发现淋巴细胞减少、铁蛋白、白细胞介素-6、乳酸脱氢酶、D-二聚体和C反应蛋白值升高与死亡率相关。COVID-19感染孕妇的病程并非总是可预测的。应结合临床和实验室数据评估疾病预后。应充分告知疫苗接种的重要性。影响声明SARS-CoV-2感染在全球范围内引发了公共卫生危机。对感染2019冠状病毒病(COVID-19)的孕妇进行研究后发现,孕产妇和围产期死亡率有所上升。尤其是在感染德尔塔变异株的患者之后,重症监护病房(ICU)的入院人数有所增加。大流行仍在以新变异株不可预测的病程持续。与大流行前时期相比,COVID-19感染导致孕产妇死亡率增加了10倍以上,尤其是在德尔塔变异株出现之后。在重症监护随访中,淋巴细胞计数低、乳酸脱氢酶、D-二聚体、C反应蛋白、铁蛋白和白细胞介素-6值高是预后不良的指标(原文此处可能有误,结合前文推测应为“是预后不良的指标”)。COVID-19感染导致孕产妇死亡率增加。考虑到我们研究中所有入住ICU的患者均未接种疫苗,应鼓励孕妇接种疫苗。